Business Context and Reporting Period
This Form 8-K Current Report was filed by The Clorox Company on October 3, 2011. The filing addresses significant changes in executive management, specifically the departure of the Chief Financial Officer and the appointment of a successor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Departure: Daniel J. Heinrich notified the Company of his intention to retire as Executive Vice President – Chief Financial Officer, effective November 16, 2011.
- Appointment: The Board of Directors appointed Stephen M. Robb (47) as Senior Vice President – Chief Financial Officer, effective November 17, 2011.
- Succession Background: Mr. Robb has served as Vice President – Global Finance since January 2011 and previously held the position of Vice President – Financial Planning and Analysis since October 2004.
Guidance, Outlook, and Risks
The filing does not provide guidance, outlook, or management commentary regarding financial performance. Regarding the new CFO appointment, the text states that Mr. Robb's compensation for the position has not yet been determined. No specific risks or contingencies related to the transition are detailed in this document.
Investor Verification Checklist
- Verify the exact transition date between the outgoing and incoming CFO (November 16-17, 2011).
- Review the attached press release (Exhibit 99.1) for additional context on the leadership change.
- Monitor future filings for the determination of Stephen M. Robb's compensation package.
- Confirm that no other executive departures or appointments are pending.